Rehman Khaja K, Ayesha Qamar, Khan Aleem A, Ahmed Niyaz, Habibullah Chittor M
Centre for Liver Diseases, Owaisi Hospital and Research Centre, Kanchanbagh, Hyderabad, India.
Cell Biochem Funct. 2004 Mar-Apr;22(2):89-96. doi: 10.1002/cbf.1061.
The ontogeny of gamma-glutamyl transferase (GGTase; E.C.2.3.2.2) and tyrosine aminotransferase (TAT; E.C.2.6.1.5) activities in 14 to 36 weeks gestational and neonatal hepatocytes during development of human fetal liver was studied. Subsequently, 20-24 weeks gestational hepatocytes were cultured in media supplemented with epidermal growth factor (EGF) and insulin with or without glucagon and dexamethasone to investigate the proliferation and differentiation of fetal hepatocyte in vitro using GGTase and TAT as biochemical markers. During the development of the liver, the activity of GGTase increased continuously from the first trimester through the third trimester and decreased (p < 0.001) in neonates. A low basal level of TAT activity was seen only during the third trimester, which then increased significantly (p < 0.001) in neonates. Fetal hepatocytes, in the presence of EGF and insulin, undergo proliferation from the fourth to 10th day with an increase in cell number (p < 0.001) and concomitant increase (p < 0.001) in GGTase activity. As the cells attain confluence, enzyme activity decreased significantly (p < 0.001) from the 10th to 16th day. Maximal TAT activity (p < 0.001) was observed at 48 h of culture, which decreased, but not significantly, during cell proliferation and the enzyme activity was regained as the cultures attained confluence. Furthermore, TAT activity was induced synergistically (p<0.001) in the presence of glucagon and dexamethasone, while GGTase was inhibited (p<0.001). These results indicate that GGTase increases with proliferation, whereas TAT, once it has been expressed, is not suppressed during cell proliferation. In conclusion, human fetal hepatocytes undergo enzymic differentiation by 48 h of culture, and proliferate with an increase in GGTase in the presence of growth factors with maintenance of differentiated status up to the studied 16 days of culture.
研究了人类胎儿肝脏发育过程中,孕14至36周的胎儿及新生儿肝细胞中γ-谷氨酰转移酶(GGTase;E.C.2.3.2.2)和酪氨酸转氨酶(TAT;E.C.2.6.1.5)活性的个体发生情况。随后,将孕20 - 24周的肝细胞培养于添加或未添加胰高血糖素和地塞米松的表皮生长因子(EGF)及胰岛素的培养基中,以GGTase和TAT作为生化标志物,研究胎儿肝细胞在体外的增殖与分化。在肝脏发育过程中,GGTase的活性从妊娠早期持续增加至晚期,在新生儿期降低(p < 0.001)。仅在妊娠晚期观察到低水平的TAT基础活性,随后在新生儿期显著增加(p < 0.001)。在EGF和胰岛素存在的情况下,胎儿肝细胞在第4至10天进行增殖,细胞数量增加(p < 0.001),同时GGTase活性也随之增加(p < 0.001)。当细胞达到汇合状态时,酶活性在第10至16天显著降低(p < 0.001)。在培养48小时时观察到最大TAT活性(p < 0.001),在细胞增殖过程中其活性降低,但不显著,当培养物达到汇合状态时酶活性恢复。此外,在胰高血糖素和地塞米松存在的情况下,TAT活性被协同诱导(p<0.001),而GGTase被抑制(p<0.001)。这些结果表明,GGTase随增殖而增加,而TAT一旦表达,在细胞增殖过程中不会被抑制。总之,人类胎儿肝细胞在培养48小时时发生酶分化,并在生长因子存在的情况下伴随GGTase增加而增殖,直至培养的第16天维持分化状态。